Citation Impact
Citing Papers
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer
2005
Gastric cancer
2016 Standout
Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
2011
Nasopharyngeal carcinoma
2005 Standout
The influence of nutritional status on complications after operations for lung cancer
2001
Apoptosis. Its significance in cancer and cancer Therapy
1994 Standout
Surgical Site Infections: Reanalysis of Risk Factors
2002
Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: Overall survival and patterns of failure
1992
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
2014 Standout
Human red cell Aquaporin CHIP. II. Expression during normal fetal development and in a novel form of congenital dyserythropoietic anemia.
1994 StandoutNobel
N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery
2005 Standout
ESPEN guideline: Clinical nutrition in surgery
2017 Standout
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
2010 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study
2004
ESPEN Guidelines on Enteral Nutrition: Surgery including Organ Transplantation
2006 Standout
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
2003 Standout
Guideline for Prevention of Surgical Site Infection, 1999
1999 Standout
POISONING BY SODIUM CHANNEL BLOCKING AGENTS
1997
Nanosilver as a new generation of nanoproduct in biomedical applications
2010 Standout
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Classical and Nonclassical HLA Class I Antigen and NK Cell–Activating Ligand Changes in Malignant Cells: Current Challenges and Future Directions
2005
Sentinel Lymph Node Mapping of the Gastrointestinal Tract by Using Invisible Light
2006 StandoutNobel
Randomized phase II study of irinotecan, leucovorin and 5-fluorouracil (ILF) versus cisplatin plus ILF (PILF) combination chemotherapy for advanced gastric cancer
2007
Bladder cancer
2016 Standout
Risk Factors for Infection After Spinal Surgery
2005 Standout
SURGICAL INFECTIONS IN PATIENTS WITH CHRONIC RENAL FAILURE
2001
A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junction
2009
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis
2000
Gastric cancer
2020 Standout
Nutritional Depletion in Staged Spinal Reconstructive Surgery
1998
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Human red cell aquaporin CHIP. I. Molecular characterization of ABH and Colton blood group antigens.
1994 StandoutNobel
One Hundred Consecutive Cases of Sentinel Lymph Node Mapping in Early Colorectal Carcinoma
2002
Active cell death in hormone-dependent tissues
1992
Early versus Late Parenteral Nutrition in Critically Ill Adults
2011 Standout
Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells
2005 StandoutNobel
Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials
2003 Standout
A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma
2008
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
MHC antigens and tumor escape from immune surveillance
2001
Antibiotic-Loaded Bone Cement for Infection Prophylaxis in Total Joint Replacement
2006
Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction
2008
Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer
2014
Prospective Randomization of Parenteral Hyperalimentation for Long Fusions With Spinal Deformity
2001
Chlorhexidine–Alcohol versus Povidone–Iodine for Surgical-Site Antisepsis
2010 Standout
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Candida Infections of Medical Devices
2004 Standout
Retrospective analysis of nasopharyngeal carcinoma treated during 1976–1985: late complications following megavoltage irradiation
1992
Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data
2006
Clustering of aberrations to specific chromosomes in human neoplasms
2009
Clustering of aberrations to specific chromosomes in human neoplasms
2009
Guideline for Prevention of Surgical Site Infection, 1999
1999 Standout
The Three Es of Cancer Immunoediting
2004 Standout
Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Untreated Metastatic Gastric Cancer: A Fédération Francophone de Cancérologie Digestive Group Study—FFCD 9803
2004
Pathogenetic significance of ?pure? monosomy 7 in myeloproliferative disorders. analysis of 14 cases
1982
ANTIBIOTIC-LOADED BONE CEMENT FOR INFECTION PROPHYLAXIS IN TOTAL JOINT REPLACEMENT
2006
Clustering of aberrations to specific chromosomes in human neoplasms
2009
Wound Microbiology and Associated Approaches to Wound Management
2001 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
The Clonal Evolution of Tumor Cell Populations
1976 StandoutScience
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
1985 StandoutNature
Molecular Characterization of Novel Reciprocal Translocation t(6;14) in an Epstein-Barr Virus-Transformed B Cell Precursor
1987 StandoutNobel
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
2012 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003
2003 Standout
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Controls of Hair Follicle Cycling
2001 Standout
Prosthetic Joint Infection
2014 Standout
Characterization of RAD9 of Saccharomyces cerevisiae and evidence that its function acts posttranslationally in cell cycle arrest after DNA damage.
1990 StandoutNobel
Fatty acids, the immune response, and autoimmunity: A question of n−6 essentiality and the balance between n−6 and n−3
2003
Part 14: Pediatric Advanced Life Support
2010 Standout
Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee.
1999 Standout
Chromosomes and Neoplasia
1979
Works of B. Klein being referenced
Lymph node-revealing solution
1997
Perioperative Nutrition and Postoperative Complications in Patients Undergoing Spinal Surgery
1996
Fatal Accidental Dibucaine Poisoning in Children
1996
A clinical evaluation of nuclear estrogen receptors combined with cytosolic estrogen and progesterone receptors in breast cancer
1990
Carcinoma of the nasopharynx in northern israel: Epidemiology and treatment results
1988
Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial
2003
The Expression of HLA Class I Antigens in Germ Cell Testicular Cancer
1990
Expression of class I histocompatibility antigens in transitional cell carcinoma of the urinary bladder in relation to survival
1991
Lymph‐node revealing solution: a new method for detecting minute lymph nodes in cystectomy specimens
1997
Effects of indomethacin treatment on human peripheral blood monocytes
1981
Ph1-positive acute lymphocytic leukemia with chromosome 7 abnormalities
1977
Two abnormal clones in the bone marrow cells of a patient with paroxysmal nocturnal hemoglobinuria
1979